Section Editors

Marc Peeters - Head of the oncology department at the Antwerp University Hospital, Coordinator of the Multidisciplinary Oncology Center Antwerp, Chairman of the College of Oncology.

Marc Peeters

Head of the oncology department at the Antwerp University Hospital, Coordinator of the Multidisciplinary Oncology Center Antwerp, Chairman of the College of Oncology.

Marc Peeters is Professor of oncology at the Antwerp University, Belgium. He is head of the oncology department at the Antwerp University Hospital and coordinator of the Multidisciplinary Oncology Center Antwerp. He is also chairman of the College of Oncology. Previously, he was Coordinator of the Digestive Oncology Unit at the University Hospital in Ghent, Belgium. He completed his medical studies at the Catholic University in Leuven, Belgium and his training in Internal Medicine at the UZ Gasthuisberg in Leuven. He underwent additional training in Oncology and Digestive Oncology at the UZ Gasthuisberg, the Institut Gustave Roussy in Villejuif – Paris, the University of Pennsylvania Hospital in Philadelphia, the Royal Marsden Hospital in London, and the Memorial Sloan-Kettering Cancer Center in New York.

Dr. Peeters is Secretary of the Flemish Society of Gastroenterology. He is treasurer of the Belgian Group of Digestive Oncology and member of the Belgian Society of Medical Oncology, The European Society of Medical Oncology, The American Society for Clinical Oncology and the gastrointestinal group of the European Organisation for Research and Treatment of Cancer.

His research interests have included the identification of molecular markers and therapy modulation in digestive tumours. He has been involved in many clinical studies on therapeutic agents for gastrointestinal tumours. He published numerous articles in peer reviewed journals and was author of several chapters in oncology books.

John L Marshall, MD - Director, The Ruesch Center for the Cure of GI Cancers; Chief, Hematology and Oncology, Lombardi Comprehensive Cancer Center, Georgetown University

John L Marshall, MD

Director, The Ruesch Center for the Cure of GI Cancers; Chief, Hematology and Oncology, Lombardi Comprehensive Cancer Center, Georgetown University

John Marshall, MD, is a global leader in the research and development of drugs for colon cancer and other GI cancers. He is the principal investigator of over 150 clinical trials, at the local as well as national levels. Dr Marshall is the clinical director of oncology for Georgetown University Hospital, associate director for clinical care of the Lombardi Comprehensive Cancer Center, and chief of the Division of Hematology-Oncology. He is widely published in the field of clinical oncology, reviews manuscripts for eight journals, and holds peer-reviewed grants from the National Institutes of Health.

In 2009, Dr Marshall became the founding director of the Otto J Ruesch Center for the Cure of Gastrointestinal Cancer. Combining expertise in molecular medicine, translational research, and a patient-centered philosophy, the Ruesch Center is dedicated to realizing the dream of individualized curative therapies through research, care and advocacy.

Dr Marshall's own research focuses on the development of a novel vaccine for the treatment of advanced colon cancer. For over a decade, he has directed Lombardi's Developmental Therapeutics Program while also maintaining his regular clinical practice. Seeing about 60 patients each week, Dr. Marshall specializes in cancers of the GI tract at all stages of the disease.

Latest Articles

Latest Videos

Video List based on Category on Node Page

Latest Videos

Editorial board member John L Marsahll from The Ruesch Center for the Cure of GI Cancers, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center in Washington, DC discusses unmet needs and major advances in the treatment of colorectal cancers, and how PARP inhibitors...
Jeff Evans, of the University of Glasgow, UK, talks to us about the advances in the clinical development of lenvatinib and its potential use in combination with pembrolizumab for the treatment of hepatocellular carcinoma. 1. What is the latest progress on the clinical development of...
Chinthalapally V Rao from the University of Oklahoma Health Sciences Center, Oklahoma City, OK, US, talks to us about the protective role of aspirin and other NSAIDs in colorectal cancer. 1. What is currently known about the protective role of aspirin and other NSAIDs in colorectal...

Gastrointestinal Oncology INSIGHTS

The touchONCOLOGY website provides a selection of resources to inform clinicians and patients about the latest developments in the field. The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of oncology:

Insight
New Study Recommends Pancreatic Cancer Screening for High-risk Patients Katrina Mountfort, Freelance Medical Writer for Touch Medical Media, UK